J.S. Allan

1.7k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

J.S. Allan is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Epidemiology. According to data from OpenAlex, J.S. Allan has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Ecology, Evolution, Behavior and Systematics and 5 papers in Epidemiology. Recurrent topics in J.S. Allan's work include T-cell and Retrovirus Studies (6 papers), Animal Disease Management and Epidemiology (5 papers) and Vector-Borne Animal Diseases (5 papers). J.S. Allan is often cited by papers focused on T-cell and Retrovirus Studies (6 papers), Animal Disease Management and Epidemiology (5 papers) and Vector-Borne Animal Diseases (5 papers). J.S. Allan collaborates with scholars based in United States, Senegal and France. J.S. Allan's co-authors include Max Essex, Françis Barin, Tae Hoon Lee, M. F. McLane, W A Haseltine, J G Sodroski, J E Coligan, JE Groopman, F. Denis and Souleymane Mboup and has published in prestigious journals such as Science, The Lancet and Journal of Biological Chemistry.

In The Last Decade

J.S. Allan

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III

1985 487 citations J.S. Allan, J E Coligan et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.S. Allan United States	11	907	525	493	274	261	15	1.4k
Maja A. Sommerfelt Norway	17	983 1.1×	622 1.2×	548 1.1×	396 1.4×	403 1.5×	43	1.6k
S P Cort United States	9	1.6k 1.7×	1.1k 2.1×	762 1.5×	380 1.4×	441 1.7×	12	2.1k
A. K. Fowler United States	18	840 0.9×	542 1.0×	624 1.3×	272 1.0×	352 1.3×	58	1.5k
Babak Banapour United States	12	1.2k 1.3×	639 1.2×	644 1.3×	267 1.0×	404 1.5×	14	1.5k
MP Busch United States	20	304 0.3×	292 0.6×	403 0.8×	211 0.8×	522 2.0×	42	1.4k
Anne L. Maerz Australia	14	1.4k 1.5×	647 1.2×	734 1.5×	331 1.2×	566 2.2×	18	1.9k
F Clavel France	17	1.6k 1.8×	408 0.8×	1.1k 2.3×	565 2.1×	481 1.8×	25	2.1k
M. F. McLane United States	17	1.6k 1.7×	1.2k 2.2×	880 1.8×	354 1.3×	684 2.6×	25	2.6k
Jean‐Claude Gluckman France	17	2.1k 2.3×	1.4k 2.6×	1.0k 2.1×	596 2.2×	646 2.5×	37	2.9k
Linda Rabin United States	15	1.6k 1.8×	1.0k 2.0×	862 1.7×	423 1.5×	605 2.3×	18	2.3k

Countries citing papers authored by J.S. Allan

Since Specialization

Citations

This map shows the geographic impact of J.S. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.S. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.S. Allan more than expected).

Fields of papers citing papers by J.S. Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.S. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.S. Allan. The network helps show where J.S. Allan may publish in the future.

Co-authorship network of co-authors of J.S. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of J.S. Allan. A scholar is included among the top collaborators of J.S. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.S. Allan. J.S. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Shoji, Takahiro, Hisashi Sahara, Ashok Muniappan, et al.. (2006). An MHC Class II Disparity Raises the Threshold for Tolerance Induction in Pulmonary Allografts in Miniature Swine. Transplantation Proceedings. 38(10). 3268–3270. 9 indexed citations

2.

Allan, J.S., John C. Wain, Douglas R. Johnston, et al.. (2002). Recipients of MHC class I disparate lung grafts develop T cell reactivity to donor MHC class I allopeptides in an orthotopic swine model. The Journal of Heart and Lung Transplantation. 21(1). 132–132. 1 indexed citations

3.

Lohman, Kenton L., et al.. (1992). Characteristics of murine monoclonal anti-CD4. Epitope recognition, idiotype expression, and variable region gene sequence. The Journal of Immunology. 149(10). 3247–3253. 10 indexed citations

4.

Rozencweig, Marcel, Mohan Beltangady, J.S. Allan, et al.. (1992). Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 80(12). 2969–2976. 19 indexed citations

5.

Rozencweig, Marcel, Mohan Beltangady, J.S. Allan, et al.. (1992). Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 80(12). 2969–2976. 26 indexed citations

6.

Allan, J.S., et al.. (1991). Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood. 78(12). 3148–3154.

7.

Attanasio, Roberta, J.S. Allan, Stephanie A. Anderson, Tran C. Chanh, & R C Kennedy. (1991). Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. The Journal of Immunology. 146(2). 507–514. 23 indexed citations

8.

Allan, J.S., et al.. (1991). Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood. 78(12). 3148–3154. 39 indexed citations

9.

Kennedy, R C, G R Dreesman, Tran C. Chanh, et al.. (1987). Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope.. Journal of Biological Chemistry. 262(12). 5769–5774. 52 indexed citations

10.

Kennedy, R C, Richard D. Henkel, Daniel Pauletti, et al.. (1986). Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope Glycoprotein. Science. 231(4745). 1556–1559. 153 indexed citations

11.

Archibald, David W., et al.. (1986). Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection. Journal of Clinical Microbiology. 24(5). 873–875. 44 indexed citations

12.

Barin, Françis, M. F. McLane, J.S. Allan, et al.. (1985). Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS Patients. Science. 228(4703). 1094–1096. 198 indexed citations

13.

Allan, J.S., J E Coligan, Françis Barin, et al.. (1985). Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-III. Science. 228(4703). 1091–1094. 487 indexed citations breakdown →

14.

Barin, Françis, F. Denis, J.S. Allan, et al.. (1985). SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA. The Lancet. 326(8469-8470). 1387–1389. 261 indexed citations

15.

Jensen, James B., et al.. (1983). Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan. Infection and Immunity. 41(3). 1302–1311. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact